ENTX ENTERA BIO LTD Expansion Plans 8-K Filing 2025 - Collaboration Agreement On March 16, 2025, Entera Bio Ltd entered a collaboration agreement with OPKO Health to develop an oral treatment for obesity and related disorders, sharing 40% of costs and proceeds, and issued 3,685,226 shares for $8 million at $2.17 each.Get access to all SEC 8-K filings of the ENTERA BIO LTD